These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11296312)

  • 1. Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.
    Rowland L; Bustillo JR; Lauriello J
    Semin Clin Neuropsychiatry; 2001 Apr; 6(2):121-30. PubMed ID: 11296312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
    Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
    Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls.
    Steel RM; Bastin ME; McConnell S; Marshall I; Cunningham-Owens DG; Lawrie SM; Johnstone EC; Best JJ
    Psychiatry Res; 2001 May; 106(3):161-70. PubMed ID: 11382538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A; Galińska B; Tarasów E; Walecki J; Dzienis W; Kubas B; Czernikiewicz A
    Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis.
    Brugger S; Davis JM; Leucht S; Stone JM
    Biol Psychiatry; 2011 Mar; 69(5):495-503. PubMed ID: 21145039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.
    Cecil KM; Lenkinski RE; Gur RE; Gur RC
    Neuropsychopharmacology; 1999 Feb; 20(2):131-40. PubMed ID: 9885793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.
    Fukuzako H; Takeuchi K; Hokazono Y; Fukuzako T; Yamada K; Hashiguchi T; Obo Y; Ueyama K; Takigawa M; Fujimoto T
    Psychiatry Res; 1995 Nov; 61(4):193-200. PubMed ID: 8748464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
    Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
    Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
    He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
    Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy.
    Omori M; Murata T; Kimura H; Koshimoto Y; Kado H; Ishimori Y; Ito H; Wada Y
    Psychiatry Res; 2000 May; 98(3):155-62. PubMed ID: 10821998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study.
    Nudmamud S; Reynolds LM; Reynolds GP
    Biol Psychiatry; 2003 Jun; 53(12):1138-41. PubMed ID: 12814865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology.
    Sanches RF; Crippa JA; Hallak JE; Araújo D; Zuardi AW
    Rev Hosp Clin Fac Med Sao Paulo; 2004 Jun; 59(3):145-52. PubMed ID: 15286836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.
    Block W; Bayer TA; Tepest R; Träber F; Rietschel M; Müller DJ; Schulze TG; Honer WG; Maier W; Schild HH; Falkai P
    Neurosci Lett; 2000 Aug; 289(2):147-51. PubMed ID: 10904141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.
    Heimberg C; Komoroski RA; Lawson WB; Cardwell D; Karson CN
    Psychiatry Res; 1998 Aug; 83(2):105-15. PubMed ID: 9818736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.